Worldwide Psychedelic Research

Friction and addiction: the use of illicit drugs in Australian research

August 6, 2012 Worldwide Psychedelic Research

Criminalisation of many drugs of abuse has done little to deter their use. Recent estimates tell us nearly one in 20 individuals aged between 15 and 64 are experimenting with illicit drug use worldwide. But contrary to the recent statements by Professor David Nutt in the UK, legislation regarding the use of illicit drugs for research purposes has had […]

Continue Reading →

Psilocybin’s effects on the brain and Aldous Huxley’s ‘reducing valve’ of consciousness: blog reaction to Beckley-Imperial Psilocybin research

January 27, 2012 LSD

In the popular science blog io9, Robert T. Gonzales ties up findings from this week’s Beckley Foundation-Imperial College Psilocybin paper in the PNAS with Aldous Huxley’s ‘reducing valve’ hypothesis, initially presented in his 1954 book The Doors of Perception (http://mescaline.com/huxley.htm); also, to more recent theorising by Karl Friston of University College London (http://www.fil.ion.ucl.ac.uk/~karl/), who postulates, in […]

Continue Reading →
Thumbnail image for Johns Hopkins Study Probes “Sacred Mushroom” Chemical

Johns Hopkins Study Probes “Sacred Mushroom” Chemical

June 16, 2011 Worldwide Psychedelic Research

This is a brilliant new study from the team at Johns Hopkins University.  The Beckley Foundation is currently collaborating on another study with the team from Johns Hopkins, led by Professor Roland Griffiths, researching the effects of psilocybin as an aid to psychotherapy for treating nicotine addiction. The results so far have been extremely promising. […]

Continue Reading →
Thumbnail image for Psilocybin Reduces Blood Flow to the Brain

Psilocybin Reduces Blood Flow to the Brain

May 16, 2011 Psilocybin

Psychedelic drug users throughout the ages have described their experiences as mind-expanding. They might be surprised, therefore, to hear that psilocybin – the active ingredient in magic mushrooms – actually decreases blood flow as well as connectivity between important areas of the brain that control perception and cognition. The same areas can be over-active in […]

Continue Reading →

Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans

December 17, 2010 Worldwide Psychedelic Research

Serotonergic hallucinogens —such as LSD, mescaline, and psilocybin— produce a bewildering variety of visual phenomena [1–7]. Visual changes include altered form and depth perception, prolonged afterimages, motion-processing impairments, vivid pseudo-hallucinations, and, only very rarely, actual hallucinations in which insight into the non-veridical nature of the experience is impaired [8–17]. Pseudo-hallucinations can occur both with the […]

Continue Reading →

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

December 17, 2010 Psilocybin

Context: Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the treatment of anxiety reactive to advanced-stage cancer. Objective: To explore the safety and efficacy of psilocybin […]

Continue Reading →